Phase 1 clinical program in healthy volunteers is ongoing in Australia; IND clearance will facilitate program expansion to assess JNT-517 in individuals with PKU. BOSTON, Jan. 6, 2023 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback